Lamotrigina Aurovitas

Lamotrigine, the active ingredient in Lamotrigina Aurovitas, is an anticonvulsant presented as an oral dosage form for oral use. It treats partial seizures in epilepsy and is used as maintenance therapy for bipolar disorder in adults.

GNH USA supplies Lamotrigina Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an anticonvulsant that modulates neuronal excitability in several neurological and psychiatric conditions. - Epilepsy (partial seizures): reduces seizure frequency and severity. - Bipolar disorder (maintenance therapy): stabilizes mood and lowers risk of depressive or manic episodes. - Generalized tonic‑clonic seizures: helps prevent seizure recurrence.

Lamotrigina Aurovitas may cause a range of adverse reactions. Patients should be aware of both frequent and infrequent events.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate pain in the head region. - Nausea: feeling of stomach upset or urge to vomit. - Rash: skin redness or irritation, often mild. - Blurred vision: temporary visual disturbances. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Blood dyscrasias: abnormal blood cell counts, such as agranulocytosis. - Hepatic failure: impaired liver function. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Severe allergic reactions: anaphylaxis or angioedema.

Before initiating therapy, clinicians should consider several safety measures. - Dose titration: increase gradually to minimize rash risk. - Skin monitoring: inspect regularly for any rash or hypersensitivity. - Liver function: assess hepatic status and adjust if impaired. - Discontinuation: avoid abrupt cessation to prevent seizure rebound. - Pregnancy: discuss potential risks with a healthcare provider. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lamotrigine can interact with several medicines, altering its plasma concentration or efficacy.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, risk of toxicity. - Carbamazepine: reduces lamotrigine concentrations, may diminish seizure control. - Phenytoin: lowers lamotrigine exposure, potentially reducing effectiveness. - Oral contraceptives: elevate lamotrigine levels, requiring dose adjustment. - Phenobarbital: decreases lamotrigine levels, may necessitate higher dosing.

Moderate Interactions (Monitor Closely): - Other antiepileptics (e.g., levetiracetam): may require therapeutic monitoring. - Antidepressants (e.g., SSRIs): watch for additive CNS effects. - NSAIDs: possible increase in lamotrigine plasma levels. - Alcohol: may enhance dizziness and sedation. - Herbal supplements (e.g., St. John’s wort): could affect metabolism.